US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares MSCI Pacific ex Japan ETF

54.98

-0.4000-0.72%

Post-market: 54.980.00000.00%16:10 EDT

Volume:237.64K

Turnover:13.08M

Market Cap:2.09B

PE:6.47

High:55.21

Open:55.12

Low:54.85

Close:55.38

52wk High:57.07

52wk Low:47.57

Shares:38.10M

Float Shares:38.10M

Volume Ratio:0.54

T/O Rate:0.62%

Dividend:1.90

Dividend Rate:3.46%

EPS(TTM):8.50

EPS(LYR):8.50

ROE:25.94%

ROA:1.81%

PB:0.98

PE(LYR):6.47

Loading ...

Overview Company News Filings

Concept

ESG ETF-MSCI-0.12%

Capital Flow

Inflow:

Outflow:

News

Press Release: Disc Medicine Reports First Quarter 2026 Financial Results and Provides Business Update

CLINUVEL receives final EMA scientific advice for pivotal Phase III vitiligo study

CLINUVEL: advancing peptides for photomedicine and vitiligo care at AAD 2026

Clinuvel Leverages AAD 2026 to Advance Vitiligo, EPP Strategy and U.S. Profile

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/EPP"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"EPP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EPP\",,,,,undefined,":{"symbol":"EPP","market":"US","secType":"STK","nameCN":"iShares MSCI Pacific ex Japan ETF","latestPrice":54.98,"timestamp":1779480000000,"preClose":55.38,"halted":0,"volume":237636,"hourTrading":{"tag":"盘后","latestPrice":54.98,"preClose":54.98,"latestTime":"16:10 EDT","volume":11,"amount":603.81,"timestamp":1779480604356,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.007222824124232677,"floatShares":38100000,"shares":38100000,"eps":8.495214,"marketStatus":"Closed Memorial Day","change":-0.4,"latestTime":"05-22 16:00:00 EDT","open":55.12,"high":55.205,"low":54.85,"amount":13075933,"amplitude":0.00641,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":8.495214,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1779782400000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":55.38,"sharesOutstanding":38400000,"nav":55.082187,"aum":2098631324.7,"dividendRate":0.034616,"bidAskSpread":0.000299,"preHourTrading":{"tag":"盘前","latestPrice":55.38,"preClose":55.38,"latestTime":"07:37 EDT","volume":7,"amount":387.66,"timestamp":1779449873367,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":54.98,"preClose":54.98,"latestTime":"16:10 EDT","volume":11,"amount":603.81,"timestamp":1779480604356,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.5358321816299455,"impliedVol":0.1626,"impliedVolPercentile":0.8765},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EPP\",,,,,undefined,":{"symbol":"EPP","floatShares":38100000,"roa":"1.81%","roe":"25.94%","lyrEps":8.495214,"volumeRatio":0.5358321816299455,"shares":38100000,"dividePrice":1.9032,"high":55.205,"amplitude":0.00641,"preClose":55.38,"low":54.85,"week52Low":47.57,"pbRate":"0.98","psRate":"30.57","week52High":57.07,"institutionHeld":0,"latestPrice":54.98,"eps":8.495214,"divideRate":0.034616,"volume":237636,"delay":0,"ttmEps":8.495214,"open":55.12,"prevYearClose":50.47,"prevWeekClose":54.98,"prevMonthClose":55.67,"prevQuarterClose":53.14,"fiveDayClose":54.99,"twentyDayClose":55.04,"sixtyDayClose":56.8},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EPP\",params:#limit:5,,,undefined,":[{"date":"2025-12-16","symbol":"EPP","amount":1.045605,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"亚太地区（除日本）ETF-iShares MSCI","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-06-16","symbol":"EPP","amount":0.858764,"announcedDate":"2025-06-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-16","defaultRemindTime":1750080600000,"name":"亚太地区（除日本）ETF-iShares MSCI","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-20","payableDate":"2025-06-16","currency":"USD","dateTimestamp":1750046400000,"payDate":"2025-06-20"},{"date":"2024-12-17","symbol":"EPP","amount":0.96746,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"亚太地区（除日本）ETF-iShares MSCI","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-20","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-20"},{"date":"2024-06-11","symbol":"EPP","amount":0.70131,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-11","defaultRemindTime":1718112600000,"name":"亚太地区（除日本）ETF-iShares MSCI","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-17","payableDate":"2024-06-11","currency":"USD","dateTimestamp":1718078400000,"payDate":"2024-06-17"},{"date":"2023-12-20","symbol":"EPP","amount":0.966028,"announcedDate":"2023-12-19","type":"dividend","market":"US","newRecordDate":"2023-12-21","defaultRemindTime":1703082600000,"name":"亚太地区（除日本）ETF-iShares MSCI","recordDate":"2023-12-27","payableDate":"2023-12-21","currency":"USD","dateTimestamp":1703048400000,"payDate":"2023-12-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EPP\",market:\"US\",,,undefined,":[{"executeDate":"2016-06-22","recordDate":"2016-06-24","paymentDate":"2016-06-28","value":0.661333,"currency":"USD"},{"executeDate":"2016-12-21","recordDate":"2016-12-23","paymentDate":"2016-12-28","value":0.90607,"currency":"USD"},{"executeDate":"2017-06-20","recordDate":"2017-06-22","paymentDate":"2017-06-26","value":0.756156,"currency":"USD"},{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-25","value":0.867553,"currency":"USD"},{"executeDate":"2018-12-18","recordDate":"2018-12-19","paymentDate":"2018-12-24","value":1.166804,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"EPP\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EPP\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2633948138","title":"Press Release: Disc Medicine Reports First Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2633948138","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633948138?lang=en_us&edition=fundamental","pubTime":"2026-05-05 20:30","pubTimestamp":1777984200,"startTime":"0","endTime":"0","summary":"-- Completed enrollment of the Phase 3 APOLLO study of bitopertin in. erythropoietic protoporphyria ; topline data expected in Q4 2026. -- Updated data from Phase 2 study of DISC-0974 in patients with anemia of. myelofibrosis  to be shared at the American Society of Clinical. -- Progressing ongoing Phase 2 study of DISC-3405 in polycythemia vera . and Phase 1b study of DISC-3405 in sickle cell disease , with data. cash, cash equivalents, and marketable securities, providing runway into. adults and adolescents with EPP, with topline data expected Q4 2026;anemia of myelofibrosis  to be shared in an oral presentation at ASCO. -- Progressing Phase 2 study in patients with inflammatory bowel disease","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EPP","LU0053671581.USD","SCD","BK4582","IRON","IBD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629926808","title":"CLINUVEL receives final EMA scientific advice for pivotal Phase III vitiligo study","url":"https://stock-news.laohu8.com/highlight/detail?id=2629926808","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629926808?lang=en_us&edition=fundamental","pubTime":"2026-04-24 13:47","pubTimestamp":1777009620,"startTime":"0","endTime":"0","summary":"“Totality of evidence” approach to evaluate SCENESSEEXECUTIVE SUMMARY final European scientific advice received for pivotal Phase III vitiligo studyEMA emphasised its “totality of evidence” approachce","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/24/3280522/0/en/CLINUVEL-receives-final-EMA-scientific-advice-for-pivotal-Phase-III-vitiligo-study.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4582","BK4087","CHMP","EPP","EMA","BK4211","CFB","III","BK4081","BK4134"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627840160","title":"CLINUVEL: advancing peptides for photomedicine and vitiligo care at AAD 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2627840160","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627840160?lang=en_us&edition=fundamental","pubTime":"2026-04-15 14:18","pubTimestamp":1776233880,"startTime":"0","endTime":"0","summary":"AAD 2026 reinforces CLINUVEL’s expertise in dermatology. Step inside CLINUVEL’s Pavilion of Photomedicine and experience the energy of AAD 2026 through an exclusive video featuring behind-the-scenes of construction, expert insights from the CLINUVEL team and immersive visuals of guests engaging within the Pavilion.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/15/3274140/0/en/CLINUVEL-advancing-peptides-for-photomedicine-and-vitiligo-care-at-AAD-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4582","EPP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624526648","title":"Clinuvel Leverages AAD 2026 to Advance Vitiligo, EPP Strategy and U.S. Profile","url":"https://stock-news.laohu8.com/highlight/detail?id=2624526648","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624526648?lang=en_us&edition=fundamental","pubTime":"2026-04-02 09:29","pubTimestamp":1775093349,"startTime":"0","endTime":"0","summary":"Clinuvel Pharmaceuticals ( ($AU:CUV) ) has issued an announcement. Clinuvel used the 2026 American Academy of Dermatology Annual Meeting in Denver ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/clinuvel-leverages-aad-2026-to-advance-vitiligo-epp-strategy-and-u-s-profile?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/clinuvel-leverages-aad-2026-to-advance-vitiligo-epp-strategy-and-u-s-profile?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EPP","BK4582"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":4,"pageCount":1,"totalSize":14,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/EPP\",params:#limit:6,delay:false,,,undefined,":[{"market":"US","name":"ESG ETF-MSCI","id":"package_us_concept_esgetfmsci","bkCode":"BK4582","changeRate":-0.001179}]}}